S. Gray: Summary: Women undergoing PGT are learning about br. ca. risk, and 10% received elevated scores. #ASHG2013

3:27pm October 25th 2013 via TweetDeck

S. Gray: 23andMe shows relative risk, and Pathway says 'take action' 10% rec'd elevated risk estimates #ASHG2013

3:25pm October 25th 2013 via TweetDeck

S. Gray: Survey demographic: 35% have family history of cancer. #ASHG2013

3:23pm October 25th 2013 via TweetDeck

S. Gray: PGen - surveyed customers of 23andMe and Pathway Genomics. http://t.co/6vfrYHBNxK #ASHG2013

3:23pm October 25th 2013 via TweetDeck

S. Gray: Hereditary http://t.co/7zzXj9OU8L.: ~18% of familial by BRCA1/2. Phenotype effect vs. pop freq and penetrance review #ASHG2013

3:20pm October 25th 2013 via TweetDeck

S. Gray: Plus: pt empowerment. Minus: lack of regulation, followup care, downstream utilization, security #ASHG2013

3:19pm October 25th 2013 via TweetDeck

S. Gray: DTC personal genomic testing - about 660K web visits, est. sales of 20-30K consumers. Potential pluses, minuses #ASHG2013

3:18pm October 25th 2013 via TweetDeck

S. Gray (Dana Farber): The PGen Study, breast cancer screening #ASHG2013

3:17pm October 25th 2013 via TweetDeck

A. Middleton: Genetic Health Pro's: realistic on impact on explaining IF, 'paternalism' and showed @westr tweets #ASHG2013

3:14pm October 25th 2013 via TweetDeck

A. Middleton: Active search for IF? Genetic Health pro's majority say 'no'. #ASHG2013

3:12pm October 25th 2013 via TweetDeck

A. Middleton: Should genomic researchers look for IF? Film: "I want to thank the actors!" #ASHG2013

3:12pm October 25th 2013 via TweetDeck

A. Middleton: IF be made available: Majority 'yes' from all groups. #ASHG2013

3:09pm October 25th 2013 via TweetDeck

A. Middleton: Americans / Canadians 'most liberal'; British / Irish most conservative about sharing genetic info #ASHG2013

3:08pm October 25th 2013 via TweetDeck

A. Middleton: Attitudes most influenced by professional background. More than country of origin. #ASHG2013

3:08pm October 25th 2013 via TweetDeck

A. Middleton: Not limited by geography, although 79% from EU, 15% from N. Am. #ASHG2013

3:07pm October 25th 2013 via TweetDeck

A. Middleton: Other health pro's: 843. #ASHG2013

3:07pm October 25th 2013 via TweetDeck

A. Middleton: Quality of data 'exceptional' - 72% answered every Q; 6944: 607 genomic researchers, 4961 public, genetic pro's 533 #ASHG2013

3:06pm October 25th 2013 via TweetDeck

A. Middleton: Recruited 455 via trad media. Social media: 4048! I realize social media is 'incredible for recruitment' #ASHG2013

3:05pm October 25th 2013 via TweetDeck

A. Middleton: Objectives: attitudes toward sharing IF. 10 short films made, neutral and unbiased presentation of the issues #ASHG2013

3:04pm October 25th 2013 via TweetDeck

A. Middleton: DDD team exploring the reporting of IF, an 'opportunistic screen' #ASHG2013

3:03pm October 25th 2013 via TweetDeck

A. Middleton: Undiagnosed dev. disorder, 'Sarah' enrolled 'Deciphering Developmental Disorders' project. #ASHG2013

3:02pm October 25th 2013 via TweetDeck

Middleton: No relation to Kate. :o) #ASHG2013

3:01pm October 25th 2013 via TweetDeck

A. Middleton (Cambridge UK): International views on sharing incidental findings from whole genome research #ASHG2013

3:01pm October 25th 2013 via TweetDeck

J. Taylor: Future plans - 100K genomes in NHS, pilot studies are underway. #ASHG2013

3:00pm October 25th 2013 via TweetDeck

J. Taylor: 40 IF variants from ACMG 57 gene list, 12 reviewed in detail, 2 remain candidates. 0.02% of families #ASHG2013

2:57pm October 25th 2013 via TweetDeck

J. Taylor: Summary chars of publications that came out from this work. HUWE1, ALG2, SPTBN1, TTN, KCNQ2, SCN5A #ASHG2013

2:51pm October 25th 2013 via TweetDeck

J. Taylor: Of novel Mendelian genes: 6 genes discovered that were missed by Sanger #ASHG2013

2:50pm October 25th 2013 via TweetDeck

J. Taylor: 2 pathogenic regulatory var's in or downstream of known candidate genes (could not find by WES, only WGS) #ASHG2013

2:50pm October 25th 2013 via TweetDeck

J. Taylor: 150 Mendelian, also CV, metabolic, 68 autoimmune, cancer etc. #ASHG2013

2:49pm October 25th 2013 via TweetDeck

J. Taylor: WGS500 at 30x, tumors at 60x, >40 phenotypes, 35 PI's with expertise for followup study #ASHG2013

2:47pm October 25th 2013 via TweetDeck

J. Taylor: Challenges to address for WES: cost, speed, informatics, genetic/functional validation; incidental findings. #ASHG2013

2:46pm October 25th 2013 via TweetDeck

J. Taylor (Oxford): "Evaluation of Clinical Utility of Whole Genome Sequencing: the WGS500 Programme" #ASHG2013

2:45pm October 25th 2013 via TweetDeck

Yu: Q&A: If no IF are found, a concern that expectations are too high from WES #ASHG2013

2:45pm October 25th 2013 via TweetDeck

Yu: Parents expect to manage flow of information to family members. Help children mature, take resp., allowing parents to choose #ASHG2013

2:42pm October 25th 2013 via TweetDeck

Yu: 92% of parents wanted all available secondary results #ASHG2013

2:41pm October 25th 2013 via TweetDeck

Yu: Most parents indicated 'we can handle bad news' due to their prior experience. #ASHG2013

2:38pm October 25th 2013 via TweetDeck

Yu: Benefit to other family members Pt "I have 19 nieces and nephews and want them to know" #ASHG2013

2:36pm October 25th 2013 via TweetDeck

Yu: Add'l motives - info a 'heads-up' for unaffected child. And inform sib's reproductive choices. Pt "If she can pass it on" #ASHG2013

2:36pm October 25th 2013 via TweetDeck

Yu: Motivation of parents - prevent future conditions, guide / ease mgmt, also impt. when parents are gone. #ASHG2013

2:35pm October 25th 2013 via TweetDeck

Yu: 1/2 college degreed; same spectrum of autism, brain malformation, CF, limb malformation. #ASHG2013

2:34pm October 25th 2013 via TweetDeck

Yu: 150 participants; My46 is a web-based tool for self-reported measurement. (Tabor prior talk) #ASHG2013

2:33pm October 25th 2013 via TweetDeck

Yu: Also - What WES do parents want to know? How do they think about it, how will they use the info? #ASHG2013

2:33pm October 25th 2013 via TweetDeck

Yu: Kids and exomes: potentially actionable results. What choice do parents have? Future autonomy for adult onset? #ASHG2013

2:32pm October 25th 2013 via TweetDeck

J. Yu (U Wash): Benefits and risks of wanting it all: how parents plan to manage their children’s exome sequencing results #ASHG2013

2:30pm October 25th 2013 via TweetDeck

Tabor: Implications: a need for more broad framing, broader timespan; more data needed for offering choice / self mgmt #ASHG2013

2:27pm October 25th 2013 via TweetDeck

Tabor: Summary: "Even bad news is good news"; future orientation; belief that knowledge is good; #ASHG2013

2:26pm October 25th 2013 via TweetDeck

Tabor: Pt: "My response to information is to go find more information." "I get data, assimilate it, and move on" #ASHG2013

2:25pm October 25th 2013 via TweetDeck

Tabor: Pt: "The tradeoff is worth it". They articulate coping strategies, including bad news and unexpected info. #ASHG2013

2:25pm October 25th 2013 via TweetDeck

Tabor: Concerns about content, a small number concerned about misuse of info (but not stopping them from participating) #ASHG2013

2:24pm October 25th 2013 via TweetDeck

Tabor: Results not wanted: "Can't think of anything". Pt: "I don't know what the menu is" #ASHG2013

2:23pm October 25th 2013 via TweetDeck